DEFA14A: Cal-Maine Foods Reports Record Fiscal 2025 Growth
Definitive Proxy Statement
Cal-Maine Foods achieved record net sales of $4.3 billion and net income of $1.2 billion in fiscal 2025, driven by higher shell egg prices due to avian influenza and strong consumer demand.
Summary
- Reported net sales of $4.3 billion for fiscal 2025, a significant increase from $2.3 billion in fiscal 2024.
- Achieved net income attributable to Cal-Maine Foods of $1.2 billion, or $24.95 per diluted share, for fiscal 2025, up from $276.3 million, or $5.69 per diluted share, in fiscal 2024.
- Average customer selling price for shell eggs was $3.134 per dozen in fiscal 2025, compared with $1.932 per dozen in fiscal 2024, primarily due to reduced industry supply from highly pathogenic avian influenza (HPAI).
- Sold 1.283 billion dozen eggs for the year, an increase from 1.148 billion dozen eggs sold in fiscal 2024, reflecting strong consumer demand.
- Returned $330.3 million in common stock dividends to stockholders, consistent with the variable dividend policy.
- Completed an underwritten public offering of common stock by the founding family, resulting in the conversion of all Class A common stock to common stock and the company ceasing to be a controlled company under Nasdaq rules.
- Purchased approximately $50 million of common stock under a $500 million share repurchase program approved on February 25, 2025, leaving approximately $450 million remaining.
- Invested approximately $60 million in ongoing organic expansion projects, expected to add 1.1 million cage-free layer hens, 250,000 pullets, and contract production of 1.2 million free-range layer hens by calendar 2025.
- Acquired ISE America, Inc.'s commercial egg assets in June 2024, adding approximately 4.7 million layer hens and expanding distribution in the Northeast and Mid-Atlantic states.
- New production from Dexter, Missouri operations has the potential to add another 1.2 million layer hens to the total flock in calendar 2025.
- Acquired certain assets of Deal-Rite Feeds, Inc. in February (fiscal 2025), including two feed mills, to enhance production efficiencies and lower feed and delivery costs.
- Completed a strategic investment with Crepini LLC in the second quarter of fiscal 2025, establishing Crepini Foods LLC, a new egg products and prepared foods joint venture.
- Completed the acquisition of Echo Lake Foods, a producer and marketer of quality prepared foods, following the end of fiscal 2025.
- Invested over $70 million in biosecurity technology, equipment, procedures, and training since 2015 to mitigate HPAI risks.
Sentiment
Score: 9
Explanation: The company reported record financial results across all key metrics, driven by strategic acquisitions, organic growth, and favorable market conditions despite industry challenges. Strong capital returns and proactive risk management further enhance the positive outlook.
Positives
- Achieved record net sales of $4.3 billion in fiscal 2025, a substantial increase from the prior year.
- Reported significantly higher net income of $1.2 billion and diluted EPS of $24.95, demonstrating strong profitability.
- Benefited from a higher average customer selling price of $3.134 per dozen, driven by favorable market conditions.
- Increased egg sales volume to 1.283 billion dozen, indicating robust consumer demand and operational capacity.
- Returned $330.3 million in common stock dividends to stockholders, reflecting strong capital allocation.
- Initiated and partially executed a $500 million share repurchase program, enhancing shareholder value.
- Successfully completed strategic acquisitions (ISE America, Deal-Rite Feeds, Echo Lake Foods) and a joint venture (Crepini Foods) to expand production capacity, improve efficiency, and diversify the product portfolio.
- Undertaking significant organic expansion projects totaling $60 million to further increase cage-free and free-range layer hen capacity.
- Ceased to be a controlled company, which may improve corporate governance and appeal to a broader investor base.
- Proactively invested over $70 million in biosecurity measures since 2015 to manage industry-specific risks like HPAI.
Negatives
- The significantly higher shell egg market prices were primarily a result of reduced supply across the industry related to highly pathogenic avian influenza (HPAI), indicating an underlying negative industry condition.
Risks
- Highly Pathogenic Avian Influenza (HPAI) continues to pose a significant risk to the industry, potentially impacting supply, production, and distribution.
- Fluctuations in shell egg market prices due to dynamic supply and demand conditions can affect financial performance.
- Challenges in managing operations safely and responsibly, especially during periods of supply shortages.
- Integration risks associated with recent acquisitions (ISE America, Deal-Rite Feeds, Echo Lake Foods) and the Crepini Foods joint venture.
- Reliance on the effectiveness and timely implementation of United States Department of Agriculture (USDA) investments and measures to address HPAI.
Future Outlook
The company expects continued growth by expanding shell egg production capacity and product mix, both organically and through strategic acquisitions. It aims to leverage existing distribution channels to extend its reach in food service and retail marketplaces, supported by its leading production scale, integrated operations, diverse product offering, and strong financial position. The company also anticipates benefiting from USDA investments to address HPAI, though these measures will require further study and time to implement.
Management Comments
- "Fiscal 2025 was an extraordinary year of growth and transformation for Cal-Maine Foods."
- "We continued to advance our strategy in a challenging and dynamic market environment and responded to new market opportunities that we believe will shape our future growth."
- "As a leader in our industry, we are mindful of our critical role in supporting the nation's food supply by providing an affordable, high-value protein option."
- "We will continue to focus on acquiring operations that align with our strategic objectives, looking at critical factors including geographic relevance, operating synergies, product portfolio expansion, proximity to customers and potential financial returns."
- "We believe that today's consumers are looking for affordable and nutritious protein options and that our shell eggs and egg products meet that need."
- "We believe we have the ability to derive value from our other strategic investments and believe there are significant opportunities to use our scale and established customer relationships to further expand our business."
- "We are excited about the new market opportunities that Echo Lake Foods provides for Cal-Maine Foods and our customers, and we look forward to working together on a successful integration."
- "We remain diligent in our efforts to mitigate future risks and minimize potential disruption to our overall production and distribution."
- "We are extremely proud of our performance in fiscal 2025, as Cal-Maine Foods has continued to demonstrate resilience through a period of unprecedented challenges for our industry."
- "We have a growth strategy focused on expanding our shell egg production capacity and product mix, both organically and through strategic acquisitions."
- "We are committed to our mission to be the most reliable and sustainable producer of fresh shell eggs, egg products and prepared foods in the United States."
Industry Context
The shell egg industry experienced reduced supply due to Highly Pathogenic Avian Influenza (HPAI), which significantly drove up market prices. Despite these supply shortages, consumer demand for shell eggs remained strong. The U.S. Department of Agriculture (USDA) announced up to $1.0 billion in investments across the industry to address HPAI, including biosecurity, regulatory relief, and vaccine research, indicating a broader industry effort to stabilize supply. Cal-Maine Foods benefited from these market conditions and actively expanded its capacity and product offerings to meet demand.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Controlled Company Status | Cal-Maine Foods has ceased to be a controlled company pursuant to the rules of The Nasdaq Stock Market following an underwritten public offering of common stock by the founding family and the conversion of all Class A common stock into common stock. | During the fourth quarter of fiscal 2025 | Likely to increase transparency and potentially broaden the investor base by aligning with standard corporate governance practices for non-controlled companies. |
Related Party Transactions
- An underwritten public offering of shares of Cal-Maine Foods common stock was sold by the company's founding family, which led to the conversion of all Class A common stock into common stock and the company ceasing to be a controlled company.
Stakeholder Impact
- Shareholders: Benefited from significant financial performance, including $330.3 million in common stock dividends and approximately $50 million in share repurchases. The change in controlled company status may impact governance and voting rights.
- Customers: Benefited from the company's efforts to meet strong demand despite industry supply shortages, and expanded product offerings including conventional, cage-free, organic, and prepared foods.
- Employees: Recognized for their steadfast commitment to managing operations safely and efficiently and meeting customer needs.
- Industry: The company's biosecurity investments and expansion efforts contribute to supporting the nation's food supply amidst HPAI challenges.
Next Steps
- Complete approximately $60 million in ongoing organic expansion projects with planned completion in calendar 2025.
- Successfully integrate the acquisition of Echo Lake Foods.
- Continue to focus on acquiring operations that align with strategic objectives, considering factors like geographic relevance, operating synergies, and product portfolio expansion.
- Leverage existing distribution channels to expand reach in food service and retail marketplaces for egg products.
- Monitor and adapt to the implementation of USDA investments and measures to address HPAI across the industry.
Key Dates
| Date | Description |
|---|---|
| Since 2015 | Invested over $70 million in best-in-class biosecurity technology, equipment, procedures, and training. |
| June 2024 | Completed the acquisition of ISE America, Inc.'s commercial egg assets. |
| Second quarter of fiscal 2025 | Completed a strategic investment with Crepini LLC, establishing Crepini Foods LLC. |
| February (Fiscal 2025) | Acquired certain assets of Deal-Rite Feeds, Inc. and its affiliated entities. |
| February 25, 2025 | Board of Directors approved a $500 million share repurchase program. |
| Fourth quarter of fiscal 2025 | Completed an underwritten public offering of common stock by the founding family, converted all Class A common stock, ceased to be a controlled company, and purchased approximately $50 million of common stock. |
| Following the end of fiscal 2025 | Completed the acquisition of Echo Lake Foods. |
| Calendar 2025 | Planned completion of approximately $60 million in ongoing organic expansion projects. |
| Calendar 2025 | New production from Dexter, Missouri, has the potential to add another 1.2 million layer hens. |
Recommendation
strong buyThe company delivered exceptional financial performance with record sales and net income, significantly exceeding prior year results. Strategic acquisitions and organic expansion projects are well underway, positioning for continued growth and diversification into value-added products. The strong financial position, robust capital return program (dividends and share repurchases), and proactive risk management (biosecurity investments) demonstrate strong operational execution and shareholder value creation. The cessation of controlled company status may also be viewed positively by institutional investors.
Keywords
Cal-Maine Foods, shell eggs, egg products, avian influenza, HPAI, financial results, net sales, net income, dividends, share repurchase, acquisitions, organic growth, cage-free, free-range, biosecurity, corporate governance, Nasdaq, controlled company
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.